The rise and fall of rofecoxib and valdecoxib demonstrate the need for caution in new drug development
Update on Healthcare Reform in 2014 under the Affordable Care Act
The American College of Rheumatology continues to monitor healthcare system changes under the ACA; educate rheumatologists, rheumatology health professionals
Why Farber Disease May Be Misdiagnosed as Juvenile Idiopathic Arthritis
A case study reveals how late presentation of this rare, autosomal-recessive disorder, which can involve arthritis-like symptoms, can be mistaken for JIA
New Treatments Needed to Prevent Fractures in Osteoporosis
Current therapies target pathways of bone remodeling, but rheumatologists say a better understanding of the mechanisms of bone resorption, formation is needed to make an impact
Treg Cells May Orchestrate Muscle Repair after Injury
New research shows the accumulation of regulatory T cells in damaged muscle corresponds with a switch in the myeloid cell infiltrate from a proinflammatory to a proregenerative phenotype.
Tacrolimus Aids Joint Remodeling in Rheumatoid Arthritis
When added to a regimen of low-dose methotrexate, the calcineurin inhibitor was found to increase bone formation in a patient with erosive RA.
Listen to Marc C. Hochberg, MD, MPH, Talk about International Collaboration
Metrics in Rheumatology: May 2014
Closer Scrutiny of Chronic Pain Patients Needed
A new study links high costs to patients with chronic pain conditions and an opioid prescription.
Improved Survival Odds Following Hip & Knee Replacements
Decreases in mortality rates following elective hip and knee replacement surgeries since 2004 may be partly due to modern surgical techniques and better pre- and post-op care.
Skin Oils Act as Natural, Tissue-Specific Autoantigens
The results of this study identify natural lipids present in the skin that augment and inhibit human T cell response, supporting the idea that lipids are T cell antigens.
- « Previous Page
- 1
- …
- 623
- 624
- 625
- 626
- 627
- …
- 816
- Next Page »